<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Inducible Knockdown Plasmodium Gene Expression <br /> Using glmS Ribozyme <br /> Parichat Prommana1, Chairat Uthaipibull1, Chayaphat Wongsombat1, Sumalee Kamchonwongpaisan1, <br /> Yongyuth Yuthavong1, Ellen Knuepfer2, Anthony A. Holder2, Philip J. Shaw1* <br /> 1 National Center Genetic Engineering Biotechnology (BIOTEC), Khlong Nueng, Khlong Luang, Pathum Thani, Thailand, 2 Division Parasitology, MRC National <br /> Institute Medical Research, London, United Kingdom <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Conventional reverse genetic approaches study Plasmodium malaria parasite gene function limited, not <br />      applicable. Hence, new inducible systems needed. Here method control P. falciparum gene expression <br />      target genes bearing glmS ribozyme 39 untranslated region efficiently knocked transgenic P. <br />      falciparum parasites response glucosamine inducer. Using reporter genes, glmS ribozyme cleaves <br />      reporter mRNA vivo leading reduction mRNA expression following glucosamine treatment. Glucosamine-induced <br />      ribozyme activation led efficient reduction reporter protein, rapidly reversed removing inducer. <br />      The glmS ribozyme validated reverse-genetic tool integration essential gene antifolate drug target <br />      dihydrofolate reductase-thymidylate synthase (PfDHFR-TS). Glucosamine treatment transgenic parasites led rapid and <br />      efficient knockdown PfDHFR-TS mRNA protein. PfDHFR-TS knockdown led growth/arrest mutant <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-122' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span>phenotype</span> and <br />      hypersensitivity pyrimethamine. The glmS ribozyme tool study essential genes P. falciparum and <br />      parasite species amenable transfection. <br />  <br />   Citation: Prommana P, Uthaipibull C, Wongsombat C, Kamchonwongpaisan S, Yuthavong Y, et al. (2013) Inducible Knockdown Plasmodium Gene Expression <br />   Using glmS Ribozyme. PLoS ONE 8(8): e73783. doi:10.1371/journal.pone.0073783 <br />   Editor: Alister G. Craig, Liverpool School Tropical Medicine, United Kingdom <br />   Received May 17, 2013; Accepted July 23, 2013; Published August 30, 2013 <br />   Copyright: &#195;&#376; 2013 Prommana et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: PJS acknowledges Bill Melinda Gates Foundation funding Grand Challenges Explorations Initiative round 4 (grant number <br />   1007041). PJS, CU, SK YY acknowledge support CPM/NSTDA grant numbers P-11-00673, P-00-20388, P-10- 10506, P-09-00707, P-12-01270. SK also <br />   acknowledges support HHMI International Scholar program. EK AAH funded UK MRC (File No. U117532067) EU FP7 Network of <br />   Excellence, EviMalar (Grant agreement 242095). The funders role study design, data collection analysis, decision publish, preparation the <br />   manuscript. <br />   Competing Interests: The authors read journal&#226;&#8364;&#8482;s policy following conflicts: PP, CU, CW, SK, YY PJS named inventors Thai <br />   patent application number 1201002492 (submitted 29 May 2012). This does alter authors&#226;&#8364;&#8482; adherence PLOS ONE policies sharing data and <br />   materials. <br />   * E-mail: philip@biotec.or.th <br />  <br />  <br />  <br /> Introduction                                                                            level target protein unaffected owing use of <br />                                                                                         alternative transcription termination site [4]. This phenomenon <br />    Malaria remains major global health problem, eradica-                          observed FLP/FRT-mediated excision [6], and <br /> tion possible understood Plasmodium                        limit general usefulness inducible gene <br /> parasite biology. Improved genetic technologies manipu-                         <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span>knockout</span> strategy Plasmodium. <br /> lation Plasmodium needed, particular robust scalable                         In contrast knockout testing loss gene function, <br /> systems conditional gene expression [1]. Genes essential                       methods available attenuating, knocking-down gene <br /> functions blood stages knocked conventionally                       expression. <span id='am-317' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-318' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-319' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-320' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-321' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-324' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-328' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-330' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-341' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-344' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-345' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-353' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-368' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-373' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-375' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-379' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-382' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-386' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-388' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-392' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-394' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span>, commonly used technique <br /> create <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span>null mutants</span> owing haploid nature parasite,                        attenuating expression model organisms, applicable in <br /> except special case gene function                               Plasmodium species lack required genes [7]. Recently, <br /> complemented chemically [2]. <span id='am-4' about='protege:TO' typeof='owl:Thing'>To</span> overcome limitation,                               shown expression essential Plasmodium genes can <br /> conditional <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-262' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-263' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-298' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span>gene knockout</span> using site-specific recombinases                          attenuated using tet-off [8]. In strategy, a <br /> been demonstrated. In approach, transgenic parasites                           transcription factor gene comprised tet repressor activating <br /> generated express recombinase controlled manner,                             domain sequence (TRAD) integrated upstream gene of <br /> either using stage-specific promoter case FLP/FRT-                          interest. The target gene&#226;&#8364;&#8482;s promoter replaced minimal <br /> mediated excision [3], ligand activation DiCre                                promoter containing tet operator sequences (TetO), are <br /> recombinase [4]. Cognate target sites recombinase                           binding sites TRAD protein. The DNA binding activity of <br /> inserted gene homologous integration                         TRAD protein regulated anhydrotetracycline (ATc), <br /> such way 39 UTR sequence excised                                   lead highly efficient knockdown (up 95% inhibition) <br /> recombinase. The control recombinase DiCre                             target gene murine malaria parasite P. berghei [8]. <br /> allows conditional knockout essential genes, shown                     Control episomal reporter gene transcription using tet-off <br /> related Apicomplexan T. gondii [5]. Despite obtaining high                              demonstrated P. falciparum [9]; however, <br /> efficiency DiCre excision P. falciparum, Collins et al.                     control endogenous P. falciparum genes method has, to <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                          1                             August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                       glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br />                                                                                 different P. falciparum loci attributed this <br />                                                                                 phenomenon [16]. <br />                                                                                    As alternative protein regulation DDs, conditional loss <br />                                                                                 gene function mediated mRNA level. Ribonu- <br />                                                                                 clease-P mediated cleavage P. falciparum essential PfgyrA <br />                                                                                 mRNA achieved using external guide sequence (EGS) <br />                                                                                 RNA, loss function phenotype demonstrated [18]. <br />                                                                                 However, clear generally useful strategy is, <br />                                                                                 target effects investigated. Moreover, the <br />                                                                                 EGS delivered modified Morpholino oligonucleotide, <br />                                                                                 synthesis requires expensive proprietary methods. <br />                                                                                 Naturally occurring self-cleaving RNAs (ribozymes) modular <br />                                                                                 elements retain function different RNA contexts, can <br />                                                                                 engineered respond ligands [19]. The Sm1 hammerhead <br />                                                                                 ribozyme functions efficiently vivo placed context of <br />                                                                                 P. falciparum mRNA; however, non-toxic specific inhibitors <br />                                                                                 ribozyme found, limiting use reverse <br />                                                                                 genetic tool [20]. <br />                                                                                    The glmS ribozyme Gram-positive bacteria unique since <br /> Figure 1. Schematic glmS ribozyme reverse genetic tool.                  specific co-factor requirement low activity during <br /> The ribozyme inserted 39-UTR coding region       normal cell growth conditions co-factor limiting [21]. <br /> is present expressed mRNA. Following addition inducer,            Moreover, glmS ribozyme shown control reporter <br /> glucosamine, binds ribozyme, mRNA self-cleaves                 gene expression Saccharomyces cerevisiae yeast response to <br /> resulting degradation mRNA knock protein                  exogenous glucosamine (GlcN) [22]. Given properties the <br /> expression. <br /> doi:10.1371/journal.pone.0073783.g001 <br />                                                                                 glmS ribozyme, tested used reverse- <br />                                                                                 genetic tool P. falciparum. In system, insertion the <br />                                                                                 ribozyme sequence target gene leads expression of <br /> our knowledge, reported. The tet-off currently               chimeric P. falciparum target RNA ribozyme RNA 39 <br /> impractical controlling endogenous P. falciparum genes            end UTR (Fig. 1). The degree ribozyme self- <br /> target gene modified double cross-over integration                cleavage, degree target gene attenuation be <br /> transgenic DNA. Double cross-over occurs low frequency                controlled concentration GlcN added parasite <br /> in P. falciparum, necessitating lengthy negative selection step            culture medium. <br /> transfection experiments [10]. The tet-off requires <br /> large transfection plasmids containing sequences homologous                  Materials Methods <br /> the target gene 59 flanking region. These 59 flanking sequences in <br /> P. falciparum typically AT-rich repetitive,                Ethics statement <br /> often difficult propagate Escherichia coli cloned                    Human O+ erythrocytes serum obtained <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> plasmids [11]. Until robust methods cloning                  healthy, non-pregnant volunteers aged 21&#226;&#8364;&#8220;50 following Thai <br /> plasmids developed making transfection DNA, tet-off                 Red Cross National Blood Center protocol. All volunteers were <br /> system experimentally challenging Plasmodium.                        recruited members public, completed and <br />    Conditional loss function phenotypes obtained                signed consent forms prior blood donation. Volunteers were <br /> P. falciparum using destabilizing domain (DD) system,              excluded donation appeared unhealthy, were <br /> protein stability controlled Shld-1 ligand [12]. Significant          course medication, high blood pressure, or <br /> down-regulation essential parasite protein levels far            had 8 hours sleep night donation. The <br /> been demonstrated successfully proteins expressed low                    consent forms protocol blood collection approved by <br /> concentration [13][14][15], consistent lower                  BIOTEC Ethics Committee. After collection blood, no <br /> efficiency DD-mediated knockdown P. falciparum compared                   records containers link individual <br /> with higher eukaryotes [12]. A recent study DD efficiency P.              donors blood donations. <br /> falciparum showed maximum difference achievable <br /> between ligand-stabilized destabilized target protein levels             Construction transfection plasmids <br /> about five-fold [16]. Analysis DD-mediated mutant phenotypes                    The pSSPF2/PfHsp60-GFP-Link plasmid described [23] was <br /> could confounded observation Shld-1 inhibits                     used construct transfection plasmids. Overlapping synthetic <br /> growth 0.5 mM, concentration needed stabilize target              oligonucleotides corresponding wild-type &#226;&#8364;&#732;&#226;&#8364;&#732;M9&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> protein [13][16]. An alternative DD similar efficiency                       mutated B. subtilis glmS ribozyme sequences reported [21] were <br /> comprised mutated E. coli DHFR domain stabilized                   combined gene synthesis-PCR resulting 166 bp <br /> by trimethoprim demonstrated P. falciparum [17]. This               ribozyme element cloned 39-UTR position downstream of <br /> system advantage stabilizing ligand                    GFP gene pSSPF2/PfHsp60-GFP-Link XhoI PstI <br /> cheaper, prior genetic modification parasite                 sites. Oligonucleotides syn1-syn8 used construct wild-type <br /> required make resistant trimethoprim, moderately potent              glmS oligonucleotides syn1-syn7 syn9 used to <br /> anti-malarial drug. The important caveat DD                         construct M9 variant (Table S1). <br /> approach limiting use large-scale reverse genetics                 The ribozyme sequences positioned upstream the <br /> the DD-fused protein function correctly,                      Plasmodium berghei dihydrofolate reductase-thymidylate synthase 39-tran- <br /> stabilized ligand. The inability integrate DD sequence             scription terminator sequence (PbDT-39). The resulting plasmids <br />                                                                                 pGFP_glmS pGFP_M9 express GFP mitochondrial <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                  2                            August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                               glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br />  <br />                                                                         RNA probe RNase protection assay; 59-P 39-P, 59 39 ribozyme <br />                                                                         cleavage products, respectively; RT-qPCR, amplicon RT-qPCR analysis <br />                                                                         reporter mRNA levels. (B) RNase protection assay revealed glmS <br />                                                                         ribozyme cleavage products (arrowed 59-P 39-P respectively) P. <br />                                                                         falciparum expressing reporter_glmS. 10% ring-stage synchronized <br />                                                                         parasites treated 24 h presence 10 mM GlcN prior <br />                                                                         harvesting extraction total parasite RNA. The 3D7 wild-type <br />                                                                         parasite used control test probe specificity. Control <br />                                                                         hybridizations gel analysis RNase (lanes 1 2 marked as <br />                                                                         -) performed demonstrate integrity RNA probe. The <br />                                                                         migration full-<span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> RNA probe complementary glmS RNA <br />                                                                         (FL probe) small RNA ladder (New England Biolabs) bands are <br />                                                                         marked. (C) Analysis reporter mRNA expression response to <br />                                                                         treatment 10 mM GlcN Fru. The expression levels of <br />                                                                         reporter_glmS mRNA reporter_M9 mRNA (bearing inactivating <br />                                                                         mutations glmS ribozyme cleavage site) treated cultures <br />                                                                         relative untreated determined RT-qPCR using DDCq <br />                                                                         method normalized BSD mRNA. Starting 10% ring-stage <br />                                                                         synchronized cultures, parasites treated 10 mM GlcN Fru <br />                                                                         24 h prior harvesting RNA extraction. Error bars represent <br />                                                                         S.E.M. (n = 7 GlcN experiments, n = 3 Fru experiments). One <br />                                                                         sample two-tailed t-tests performed determine change in <br />                                                                         mRNA expression significant; NS denotes significant, *** <br />                                                                         denotes highly significant. The calculated P-values comparing sample <br />                                                                         means hypothetical mean = 1 were: reporter_glmS GlcN <br />                                                                         treatment, ,0.0001; reporter_M9 GlcN treatment, 0.5136; repor- <br />                                                                         ter_glmS Fru treatment, 0.3986; reporter_M9 Fru treatment, 0.0619. <br />                                                                         doi:10.1371/journal.pone.0073783.g002 <br />  <br />  <br />                                                                         transit peptide P. falciparum heat shock protein 60. This open <br />                                                                         reading frame control 59 39 flanking sequences <br />                                                                         P. falciparum heat shock protein 86 (Pfhsp86 59) PbDT-39, <br />                                                                         respectively. The P. falciparum dihydrofolate reductase-thymidylate <br />                                                                         synthase (PfDHFR-TS) gene amplified PCR a <br />                                                                         previously described plasmid [24] using oligonucleotide primers <br />                                                                         dhfr-F dhfr-R cloned pGFP_glmS pGFP_M9 via <br />                                                                         unique BglII KpnI sites. The resulting plasmids pDHFR- <br />                                                                         TS-GFP_glmS pDHFR-TS-GFP_M9 study episomal <br />                                                                         reporter gene activity (Fig. 2 3) contain PfDHFR-TS-GFP <br />                                                                         open reading frame control Pfhsp86 59, glmS <br />                                                                         ribozyme           PbDT-39       flanking    sequences.     The <br />                                                                         pJRTS_GFP_glmS plasmid integration endogenous P. <br />                                                                         falciparum PF3D7_0417200 locus encoding PfDHFR-TS made <br />                                                                         restriction digestion pDHFR-TS_GFP_glmS SpeI, <br />                                                                         followed re-ligation plasmid backbone. <br />  <br />                                                                         Parasite culture transfection <br />                                                                            Plasmodium falciparum malaria parasites, strain 3D7 cultured <br />                                                                         vitro human O+ erythrocytes (5% haematocrit) RPMI-1640 <br />                                                                         medium (Invitrogen) supplemented 0.3 g/l L-glutamine, 5 g/ <br />                                                                         l hypoxanthine 10% pooled human serum an <br />                                                                         atmosphere 1% O2 5% CO2 described previously <br />                                                                         [25]. Pooled human serum heat inactivated 56uC for <br />                                                                         45 min prior use culture. Ring-stage synchronized parasites <br />                                                                         obtained consecutive sorbitol treatments described <br />                                                                         [26]. Parasite transfection performed described [27]. <br />                                                                         Transfectants obtained selection blasticidin 2 mg/ <br />                                                                         ml. Blasticidin-resistant transgenic parasites obtained 2&#226;&#8364;&#8220; <br />                                                                         3 weeks selection. Integration pJRTS_GFP_glmS plasmid <br />                                                                         achieved blasticidin on/off cycles weeks <br />                                                                         duration each, followed parasite cloning using limiting <br /> Figure 2. glmS ribozyme cleavage control P. falciparum <br />                                                                         dilution method 96-well microtiter plate. The presence of <br /> mRNA expression. (A) Schematic diagram DHFR-TS-GFP               integrated transgenic DNA blasticidin selected parasites was <br /> reporter gene glmS ribozyme 39-UTR position (repor-         determined PCR total parasite genomic DNA using <br /> ter_glmS). The reporter gene flanked 59-hsp86 PbDT-39         KAPA HiFi DNA polymerase (Kapa Biosystems) 0.3 mM of <br /> Plasmodium transcriptional regulatory sequences. The sequence           primer 10&#226;&#8364;&#8220;30 ng genomic DNA template 25 ml <br /> regions analyzed parts B C marked: FL probe, antisense <br />                                                                         reactions. Primer annealing performed 64uC 5IntF <br />  <br />  <br /> PLOS ONE | www.plosone.org                                          3                            August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                           glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br />  <br />  Table 1. Genes showing significant changes expression DHFR-TS-GFP_glmS integrant parasites GlcN treatment. <br />  <br />  <br />  Plasmodb              Product                                         uncorrected         FDR-adj.           log2 (T/U)        log2 (T/U) 3D7 <br />  Gene ID               Description                                     P-value             P-value            integrant*        wild-type* <br />  <br />  PF3D7_0417200         Bifunctional dihydrofolate reductase-           9.47E-25            2.22E-21           21.81             0.92 <br />                        thymidylate synthase (PfDHFR-TS) <br />  PF3D7_0218500         Small nuclear ribonucleoprotein Sm              6.65E-12            7.78E-09           1.53              0.71 <br />                        D2 (SNRPD2) <br />  PF3D7_0503400         Actin-depolymerizing factor 1 (ADF1)            3.09E-11            2.41E-08           1.27              0.30 <br />  PF3D7_0830400         Conserved Plasmodium protein, unknown           2.28E-08            1.33E-05           -0.93             20.97 <br />                        function <br />  PF3D7_0624500         Anaphase promoting complex subunit,             4.99E-07            2.34E-04           20.89             20.44 <br />                        putative <br />  PF3D7_0312300         26S proteasome regulatory subunit S14,          4.01E-06            1.56E-03           20.94             20.09 <br />                        putative <br />  PF3D7_0821800         Secretory complex protein 61 beta               2.26E-05            7.54E-03           21.54             21.08 <br />                        subunit (Sec61-beta) <br />  PF3D7_1103700         Casein kinase II beta chain (CK2beta1)          1.52E-04            3.53E-02           20.64             20.06 <br />  PF3D7_1124900         60S ribosomal protein L35, putative             1.66E-04            3.53E-02           20.62             20.48 <br />  PF3D7_1403400         Conserved Plasmodium protein, unknown           2.34E-04            4.57E-02           1.05              0.21 <br />                        function <br />  <br />  *Changes gene expression shown log2 mean normalized ratio GlcN treated untreated 2 replicates. <br />  doi:10.1371/journal.pone.0073783.t001 <br />  <br />  <br /> and 5IntR pair 55uC pairs. Sugars parasite                6% NovexHTBE-Urea gel (Invitrogen). The separated RNA <br /> treatments (Glucosamine (GlcN), fructose, (Fru) mannose (Man),                     samples transferred BiodyneH PLUS membrane (Pall) by <br /> mannosamine (ManN) galactosamine (GalN)) obtained                         electrotransfer 0.56 TBE running buffer (Invitrogen) and <br /> from Sigma-Aldrich dissolved 16phosphate buffered saline                    biotin-labeled RNA species detected using PhototopeH-Star <br /> (16PBS: 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 2 mM                                detection kit (New England Biolabs). <br /> KH2PO4, pH 7.4). <br />                                                                                    Reporter gene expression study reverse-transcription <br /> RNA experiments                                                                    quantitative PCR (RT-qPCR) <br />   Synchronized ring stage parasites treated 24 h                      DNA-free RNA samples (1 mg each) reverse-transcribed <br /> presence 10 mM GlcN, 10 mM Fru 16 PBS (untreated                             oligo dT(21) 20 ml reactions 50uC 1 h using <br /> control). Parasites harvested (typically yielding approximately               SuperScriptIII enzyme recommended manufacturer <br /> 10% trophozoites) liberated erythrocyte host cells                 (Invitrogen). Control reverse-transcription (RT) reactions lacking <br /> saponin lysis (0.15% w/v saponin 16 PBS). Total RNA                         RT enzyme (-RT) performed alongside +RT reactions. <br /> extracted parasites using TRizol reagent following                    The RT reactions diluted 1:100 nuclease-free water. <br />                                                                                                                         TM <br /> manufacturer&#226;&#8364;&#8482;s recommendations (Invitrogen). Genomic DNA                           qPCR performed using SsoFast EvaGreenH Supermix (Bio- <br /> was removed using Turbo DNA-freeTMkit (Applied Biosystems).                      Rad) 20 ml reactions. Each reaction contained 16 Supermix, <br /> RNA samples qualified Nanodrop (A260:280 .2:1)                         1 ml diluted cDNA template 0.5 mM oligonucle- <br /> 1% denaturing agarose gel electrophoresis (prominent 28S                       otide primer. The qPCR program used was: 95 uC 3 min, <br /> 18S rRNA bands relative ratio 1:1 greater).                                followed 40 cycles 95uC 15 s, 55uC 20 s 72uC 30 s an <br />                                                                                    iQ5 thermal cycler (Bio-Rad). PCR product threshold cycles (Cq) <br /> RNase protection assay                                                             calculated automatically iCycler program (Bio-Rad) <br />    Riboprobe template synthesized PCR amplification                         using default settings. In addition &#226;&#8364;&#8220;RT controls, no- <br /> from pGFP_glmS plasmid oligonucleotide primers glmSF                      template control performed primer pairs all <br /> glmSR-T7 (Table S1). The PCR product gel-purified using                      experiments. No product detected (no reported Cq) these <br /> QIAGEN MinElute kit. Labeled antisense riboprobe correspond-                       controls experiment. Single amplicons expected size <br /> ing 218 nt GFP_glmS region (Fig. 2A) synthesized                  observed primer pairs thermal melt assay 2% <br /> in vitro transcription T7 RNA polymerase 0.2 mM biotin-                   agarose gel electrophoresis. Under conditions used, primer <br /> 16-UTP recommended manufacturer (Fermentas). DNA                         pair efficiencies 2.01 2.02 glmS BSD pair <br /> template removed probe DNaseI digestion using                    respectively (Fig. S1). Relative changes gene expression were <br /> Turbo DNA-freeTM kit. Total parasite RNA (20 mg) isolated                      calculated using DDCq method [28]. <br /> from reporter_glmS transgenic parasite expressing reporter gene <br /> and 3D7 parental parasites treated 10 mM                       Western immunoblot <br /> GlcN 24 h. The purified RNA incubated approxi-                           Transgenic P. falciparum parasites expressing DHFR-TS-GFP <br /> mately 15 ng biotin-labeled probe overnight 42uC using                    (reporter_glmS, reporter_M9 DHFR-TS-GFP_glmS integrant) <br />           TM <br /> RPAIII kit (Applied Biosystems). RNase digestion per-                          cultured 100 ml synchronized 8&#226;&#8364;&#8220;10% ring-stages. <br /> formed 1:1000 dilution RNaseA/T1 enzyme kit                       The culture divided equally plates GlcN added <br /> for 15 min 37uC. Purified, denatured samples separated                  (10 mM final). Parasites harvested immediately from <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                     4                              August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                     glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br />  <br />  <br /> Figure 3. Ribozyme-mediated knockdown reporter protein expression response sugar treatment. Ring-stage synchronized <br /> parasites reporter_glmS (parts A, C) reporter_M9 (parts B, D) transfected lines treated 24 h varying concentrations different <br /> sugars (GlcN, ManN, GalN, Fru Man) prior flow cytometric analysis. The numbers GFP positive viable cells normalized untreated <br /> controls, set 100%. Data mean triplicate experiments error bars represent S.E.M. Part E shows ribozyme-mediated <br /> knockdown reporter protein reversible. 10% ring-stage parasites treated 10 mM GlcN 24 h samples taken 12 24 h of <br /> treatment. The parasite culture medium changed culture continued, samples taken 12 24 h new GlcN-free <br /> medium. The experiment performed triplicate independent cultures replicate (5 sampled time points culture). Western <br /> immunoblot analysis DHFR-TS-GFP reporter protein expression performed using anti-GFP polyclonal antibody. The normalized intensity of <br /> the ,100 kDa band corresponding DHFR-TS-GFP protein measured relative normalized intensity 0 h, taken 100%. Data <br /> are mean error bars represent S.E.M. Representative images Ponceau S staining parasite lysates following electrophoresis transfer <br /> to membrane, corresponding chemiluminescent detection GFP specific antibodies shown F. The pre-stained marker lane is <br /> marked M Ponceau S panel, sizes marker proteins indicated. <br /> doi:10.1371/journal.pone.0073783.g003 <br />  <br /> one plate (0 h time point), rest placed culture.              (determined Bio-Rad Bradford assay) denatured in <br /> Parasites harvested 12 24 h GlcN treatment. The             NuPAGE 16 LDS buffer NuPAGE 16 reducing agent for <br /> medium removed fourth plate 75 ml fresh                   20&#226;&#8364;&#8220;30 min 70uC electrophoresis NuPAGE Novex 4&#226;&#8364;&#8220; <br /> medium lacking GlcN added. The sub-cultured parasites (,2&#226;&#8364;&#8220;                12% Bis-Tris gel NuPAGE MOPS SDS running buffer <br /> 3% parasitemia) divided plates cultures                   (Invitrogen). The proteins transferred nitrocellulose <br /> continued 24 h. Parasites harvested 12             membrane (Protran BA85, 0.45 mm, Whatman) electro-transfer <br /> 24 h culture fresh medium (36 48 h time points).                   (30 V constant 90 min) NuPAGE transfer buffer using a <br /> Parasitized cells harvested sample centrifuga-              XCell II blot module (Invitrogen). The membrane stained <br /> tion. Parasites liberated erythrocytes saponin lysis             0.1% Ponceau S 5% acetic acid 2 min de-stained <br /> and resuspended deionised water containing protease inhibitors             deionized water. The Ponceau S-stained membrane was <br /> (0.7 mM Pepstatin (Roche) 16 Complete EDTA-free protease                  scanned using flat-bed scanner densitometric lane analysis <br /> inhibitor cocktail (Roche)). Proteins extracted freeze-               normalization sample loading transfer variation was <br /> thawing. Fifteen micrograms soluble parasite protein sample                performed using NIH ImageJ software. Membranes blocked <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                5                            August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                    glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br />  <br />  <br /> Figure 4. Integration glmS ribozyme sequence the <br /> essential PfDHFR-TS gene. (A) Schematic showing strategy used <br /> to incorporate GFP glmS ribozyme sequences 39 end of <br /> the PfDHFR-TS gene single crossover homologous recombination. <br /> The expected sizes PCR products shown B marked. (B) PCR <br /> testing plasmid integration cloned transgenic lines, clone <br /> #1 #2. PCR primer combinations used indicated the <br /> lanes migrations 1 kb+ DNA marker (Invitrogen) bands are <br /> indicated left. <br /> doi:10.1371/journal.pone.0073783.g004 <br />  <br /> for hour 5% (w/v) skimmed milk TBST (10 mM Tris- <br /> HCl pH 8.0, 150 mM NaCl 0.05% Tween 20). DHFR-TS- <br /> GFP protein detected using anti-GFP epitope tag <br /> polyclonal antibody (Thermo Scientific #PA1-19431) primary <br /> antibody diluted 1:1000 5% skimmed milk/TBST a <br /> peroxidase labeled goat anti- rabbit IgG secondary antibody <br /> (Vectorshield # Q0506) diluted 1:10 000 5% skimmed milk/ <br /> TBST. Bound antibody detected using SuperSignal West                   Figure 5. Ribozyme-mediated control endogenous PfDHFR- <br />                                                                              TS expression. (A) Knockdown PfDHFR-TS expression DHFR-TS- <br /> Pico chemiluminescence kit (Thermo Scientific). Measurement               GFP_glmS integrant parasite clonal lines response GlcN. Parasitized <br /> DHFR-TS-GFP protein expression performed using                         erythrocytes expressing PfDHFR-TS-GFP enumerated flow <br /> ChemiDocTM XRS+ imaging (Bio-Rad).                                    cytometry based level GFP fusion partner. Extra sum-of- <br />                                                                              squares F- test comparing individual curve fits null hypothesis <br />                                                                              slope EC50 clone #1 #2, P = 0.19. (B) <br /> Flow cytometry analysis                                                      Ribozyme-mediated knockdown DHFR-TS-GFP protein reversible. <br />    Transgenic P. falciparum expressing DHFR-TS-GFP protein                   DHFR-TS-GFP_glmS integrant parasite clone #1 cultured and <br /> (reporter_glmS, reporter_M9 DHFR-TS-GFP_glmS integrant)                  treated GlcN, western immunoblotting quantify DHFR-TS- <br /> were cultured synchronized 1% ring form fresh human              GFP protein performed described Fig. 3. Data mean <br /> red blood cells 2% haematocrit. 0.09 ml cultured parasites             triplicate experiments error bars represent S.E.M. (C) <br /> were transferred individual wells standard 96-well                   Representative images Ponceau S staining parasite lysates <br />                                                                              following electrophoresis transfer membrane, chemilumi- <br /> microtiter plate vitro culture continued 24 h                nescent detection GFP using specific antibodies. The pre-stained <br /> 0.01 ml sugar different concentrations well. The               marker lane marked M Ponceau S panel, sizes of <br /> parasitized erythrocytes analyzed using flow cytometer                marker proteins indicated. <br /> (Cytomics FC 500 MPL, Beckman Coulter) equipped                       doi:10.1371/journal.pone.0073783.g005 <br />  <br />  <br /> PLOS ONE | www.plosone.org                                               6                            August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                     glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br />  <br />  <br /> Figure 6. Ribozyme-mediated PfDHFR-TS knockdown phenotype. Parasite growth cultures DHFR-TS-GFP_glmS integrant (A) wild- <br /> type 3D7 (B) treated varying levels GlcN 72 h determined counting 1000 infected erythrocytes Giemsa-stained slides for <br /> each treatment time point. The data mean triplicate experiments error bars represent S.E.M. The morphology treated parasites at <br /> different time points treatment shown DHFR-TS-GFP_glmS integrant (C) wild-type 3D7 (D). Panels representative images Giemsa- <br /> stained slides. Scale bars, 5 mm. Anti-malarial drug inhibition assays pyrimethamine (E) chloroquine (F) performed presence (+ <br /> GlcN) absence (-GlcN) 2.5 mM GlcN parasite culture. The IC50 values shown fitted values independent experiments and <br /> error bars represent 95% C.I. Extra sum-of-squares F-test P-values comparing individual curve fits null hypothesis slope IC50 are <br /> the + GlcN &#226;&#8364;&#8220; GlcN: DHFR-TS-GFP_glmS integrant pyrimethamine P,0.0001; wild-type 3D7 pyrimethamine P = 0.7138; DHFR-TS- <br /> GFP_glmS integrant chloroquine P = 0.4554; wild-type 3D7 chloroquine P = 0.7898. <br /> doi:10.1371/journal.pone.0073783.g006 <br />  <br /> 488 nm laser. 50,000 cells sorted sample. The CXP                    620/25 nm band-pass filter. The numbers GFP-expressing or <br /> program (Beckman Coulter) used analyze data                        viable parasites normalized untreated control parasite <br /> obtained. To determine proportion parasitized cells                   samples experiment, taken 100%. <br /> expressed GFP background, 525/40-nm band-pass filter <br /> (FL1) employed gate threshold 100 arbitrary units.              Anti-malarial drug inhibition assays <br /> This threshold determined control experiments human                     Transgenic P. falciparum DHFR-TS-GFP_glmS integrant wild- <br /> erythrocytes infected non-GFP expressing 3D7 P. falciparum               type 3D7 parasites tested sensitivity pyrimethamine <br /> (Fig. S2). To determine parasite viability, 0.1 ml parasitized             chloroquine antimalarial drugs. 0.09 ml cultured ring-stage <br /> erythrocyte culture incubated 0.1 ml 10 mg/ml                     synchronized parasites transferred individual wells a <br /> hydroethidine (HE, Invitrogen) 20 min 37uC dark.                standard 96-well microtiter plate described vitro <br /> The HE-stained parasitized erythrocytes analyzed using <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                7                            August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br /> culture continued 48 h, 0.01 ml anti-malarial drug          reporter mRNA quantified reverse transcription quantitative <br /> different concentrations well. SYBR Green I               PCR (RT-qPCR) significantly reduced approx- <br /> added parasitized cells counted flow cytometry         imately three-fold reporter_glmS parasites exposed 10 mM <br /> as described above. For experiments GlcN, 2.5 mM GlcN                 GlcN 24 h, unchanged response 24 h treatment <br /> was added wells (drug control untreated). The SYBR              10 mM Fru (Fig. 2C). In contrast, change reporter <br /> Green I signals drug-treated samples normalized                 mRNA observed treatment transfected parasites <br /> untreated control parasite samples experiment,           expressing reporter gene, carrying glmS ribozyme <br /> were taken 100%. IC50 values 95% C.I. calculated              inactivating mutations ribozyme cleavage site <br /> from independent experiments.                                         (reporter_M9 parasites). <br />                                                                               Next, order determine effect ribozyme control of <br /> RNA-Seq                                                                    gene expression protein level, parasitized erythrocytes <br />    Transgenic DHFR-TS-GFP_glmS 3D7 wild-type parasites                 expressing reporter genes treated different sugars 24 h <br /> were cultured synchronized vitro described above. Ring-          enumerated flow cytometry. The reporter_glmS gene <br /> stage parasites treated 24 h presence 10 mM             activity diminished markedly response GlcN (EC50 = 2 mM, <br /> GlcN 16 PBS. Total RNA obtained parasites               95% C.I. 1.7 2.5 mM), weaker attenuation using <br /> described 10&#226;&#8364;&#8220;20 mg sample submitted             sugars including Fru, Man, ManN GalN (Fig. 3A). The <br /> BGI-Hong Kong RNA-Seq paired-end transcriptome sequenc-                reporter_M9 parasites expressing reporter mutated <br /> ing single lane Illumina HiSeq2000 101PE platform.              ribozyme did respond sugar treatment (Fig. 3B), thus <br /> Poor quality reads removed data (reads                  demonstrating specificity inducible system. The <br /> adaptors, .10% bases call, .50% <span id='am-395' about='xsp:base' typeof='owl:Thing'>base</span> calls             markedly different response 10 mM GlcN repor- <br /> Phred score ,5) remaining acceptable reads mapped             ter_glmS reporter_M9 parasites apparent by <br /> to P. falciparum 3D7 version 3 genome SOAP2                   microscopy (Fig. S3). Parasite viability, assessed enumerating <br /> program [29]. From mapped reads, alternative splicing events           hydroethidine stained parasites, unaffected treat- <br /> were analyzed using MATS algorithm [30] using default              ments (Fig. 3C, D). In order test quickly ribozyme- <br /> parameters, pairwise combinations samples             attenuated reporter protein recover GlcN withdrawn, <br /> tested. Differential gene expression determined using              western immunoblotting experiments performed repor- <br /> edgeR algorithm [31]. Genes fewer mapped reads           ter_glmS reporter_M9 parasites cultured 48 h cell <br /> any replicate excluded, leaving total 2316 (DHFR-TS-             cycle (Fig. 3E, F). In presence 10 mM GlcN, reporter <br /> GFP_glmS transgenic line) 2285 (3D7 wild-type) annotated               protein efficiently knocked approximately 10 fold after <br /> genes analysis. The trimmed mean M values (TMM)                 24 h treatment reporter_glmS parasites. Twelve hours after <br /> determined separately sample group used calculate           GlcN withdrawn (36 h time point), reporter protein <br /> normalization factors. The raw data results MATS              recovered level comparable reporter_M9 <br /> and edgeR analyses submitted NCBI GEO                     control. These results demonstrate glmS ribozyme be <br /> database series accession number GSE43125.                           used attenuate gene expression consistent temporal <br />                                                                            manner P. falciparum means GlcN-induced ribozyme <br /> Statistical analyses                                                       cleavage. <br />    Dose-response curves fitted normalized cell count data <br /> from experiments combined using sigmoidal dose response            Reverse-genetics using glmS ribozyme P. <br /> function variable slope Prism v4.0 (GraphPad Software              falciparum <br /> Inc.). Hill coefficient, Effective Concentration ligand producing          To assess potential reverse genetics using glmS <br /> 50% maximum response (EC50) half-maximal inhibitory                 ribozyme, ribozyme sequence integrated locus <br /> concentration (IC50) values calculated weighting.             PF3D7_0417200 (Fig. 4A). This gene encodes essential <br /> The maximum minimum responses constrained 100                  bifunctional enzyme PfDHFR-TS, target antifolate <br /> and 0% respectively. One sample two-tailed t-tests extra sum-          anti-malarial drugs, including pyrimethamine recently <br /> of-squares F- tests performed using Prism v4.0 P-             developed compound P218 [32]. To facilitate monitoring of <br /> value significance 0.05. A False Discovery Rate (FDR)              DHFR-TS expression, GFP fused C-terminal end <br /> adjusted P-value threshold 0.05 used significance            make DHFR-TS-GFP fusion protein transgenic <br /> RNA-Seq data analyses.                                                     parasite. Two clonal lines parasites expected <br />                                                                            integration obtained (Fig. 4B). Addition GlcN the <br /> Results                                                                    integrant parasite culture medium led dose-dependent decrease <br />                                                                            DHFR-TS-GFP protein expression 24 h, shown by <br /> Testing glmS ribozyme function P. falciparum                            flow-cytometric enumeration GFP positive parasites (Fig. 5A). <br />    The potential glmS ribozyme-mediated control P.                  The GlcN response clone #1 showed EC50 0.8 mM <br /> falciparum gene expression tested using episomally            (95% C.I. 0.6 1.0 mM), significantly different <br /> expressed reporter gene P. falciparum dihydrofolate reductase-          clone #2. All experiments performed on <br /> thymidylate synthase (PfDHFR-TS) fused C-terminal GFP.                  clone #1. Western immunoblotting showed attenuation of <br /> Wild-type glmS ribozyme appended flanking 39 UTR                DHFR-TS-GFP integrant reversible withdrawal <br /> downstream open reading frame (Fig. 2A). RNase                      GlcN led rapid recovery protein expression (Fig. 5B, C). <br /> protection assay performed antisense RNA probe                    In order validate glmS ribozyme specific reverse- <br /> spanning ribozyme cleavage site. From experiment, RNA             genetic tool, parasite transcriptomes 24 h treatment or <br /> species corresponding ribozyme-cleaved RNA detected                10 mM GlcN studied RNA-Seq. Overall, parasite <br /> from transfected parasites expressing reporter gene-ribozyme               response GlcN modest alternative splicing events <br /> RNA, indicating ribozyme expressed RNA                  induced GlcN treatment detected. Ten genes showed <br /> and underwent cleavage expected (Fig. 2B). The level                 significant change expression integrant gene <br />  <br />  <br /> PLOS ONE | www.plosone.org                                             8                          August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                  glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br /> showing significant change expression                        mutant M9 useful control. From RNA-Seq, some <br /> PF3D7_0417200 (PfDHFR-TS), reduced approximate-                    genes down-regulated response GlcN wild-type <br /> ly three-fold (Table 1).                                                     3D7 parasite (Table S2). For genes, confounding effect of <br />    Next, longer treatments GlcN performed test                  GlcN expression control parasite interfere with <br /> whether lead loss-of-function phenotype               phenotypic analysis knocked-down transgenic parasite. To <br /> integrant parasite. A marked GlcN dose-dependent reduction                overcome limitation, metabolite controlled ribozymes <br /> integrant parasite development reinvasion erythrocytes            theophylline-inducible aptazyme [35] warrant further <br /> observed growth cycle (Fig. 6A). In contrast, slight               investigation reverse-genetic tools. <br /> growth retardation observed wild&#226;&#8364;&#8220;type 3D7 parasites                The glmS ribozyme-mediated knockdown PfDHFR-TS led to <br /> at 5 mM GlcN (Fig. 6B). Abnormal transgenic DHFR-TS-GFP                      growth defect, consistent accepted notion gene <br /> glmS parasite morphology observed 48 h                     essential P. falciparum. Although PfDHFR-TS knockdown is <br /> exposure 5 mM GlcN, majority parasites                  detectable 12 h GlcN treatment (Fig. 5B), overall <br /> next cycle 72 h showed evidence delay abnormal             transcriptional response parasite limited and <br /> development 2.5 5 mM GlcN treatments (Fig. 6C).                   morphological changes observed 48 h of <br /> Among minority wild&#226;&#8364;&#8220;type 3D7 parasites, abnormal                        treatment. Lethal concentrations antifolates targeting PfDHFR- <br /> morphology (slightly shrunken trophozoites) observed                TS elicit weak transcriptional response, morphological <br /> after 72 h treatment 5 mM GlcN (Fig. 6D). In addition              defects observable 24 h drug exposure [36]. In <br /> growth defect, GlcN-induced reduction DHFR-TS-GFP                         addition knockdown phenotype, glmS ribozyme-mediated <br /> protein integrant parasites sensitized pyrimethamine,             knockdown PfDHFR-TS hypersensitized parasite to <br /> but chloroquine, drug targeting heme crystallization. GlcN             pyrimethamine. This result consistent PfDHFR-TS the <br /> had effect wild&#226;&#8364;&#8220;type 3D7 parasite sensitivity            target pyrimethamine using logic yeast <br /> drug (Fig. 6E, F).                                                           haploinsufficient DFR1 encoding dihydrofolate reductase are <br />                                                                              hypersensitive methotrexate, potent antifolate drug [37]. <br /> Discussion                                                                   Likewise, envisioned collection transgenic <br />                                                                              parasites glmS ribozyme integrated different essential genes <br />    We demonstrated glmS ribozyme active P.               used systematically identify anti-malarial compound <br /> falciparum used tool modulate target gene                 mode action accelerate drug discovery this <br /> expression transgenic parasites. Reverse-genetics understand           important pathogen. We caution testing of <br /> the function essential parasite genes possible glmS           glmS ribozyme tool gene targets required order to <br /> ribozyme tool requirement promoter modification              determine generally useful strategy is. It known <br /> or protein fusion destabilizing domains. The level P. falciparum       genes expressed abundantly PfDHFR-TS, or <br /> target protein knockdown achievable comparable                     expressed different <span id='am-396' about='xsp:pattern' typeof='owl:Thing'>pattern</span> life cycle be <br /> previously described DD inducible system. On hand,                 efficiently regulated glmS ribozyme tool. <br /> the glmS ribozyme DD systems combined provide                   Furthermore, glmS ribozyme active expressed <br /> an greater control target protein, provided DD              39-UTR target genes, applied easily for <br /> does interfere target protein function.                         knockdown essential genes parasite species amenable to <br />    The RNA experiments Fig. 2 demonstrated glmS ribozyme                  transfection homologous recombination, species <br /> cleavage target P. falciparum mRNA. The three-fold reduction           little known gene regulation Eimeria sp. and <br /> mRNA induction ribozyme cleavage attributed               Babesia bovis. <br /> mRNA degradation cytoplasmic 39 exosome machinery, as <br /> described Saccharomyces cerevisiae yeast [33]. In work,       Supporting Information <br /> shown ribozyme-cleaved mRNA 59 fragment separated <br /> from polyA tail rapidly degraded wild-type yeast,           Figure S1 RT-qPCR assay validation. (A) Determination of <br /> stable ski7 mutant yeast defective 39 exosome function. In         qPCR primer pair efficiencies amplification cDNA dilutions. <br /> our experiments, glmS ribozyme positioned 39 UTR              Each point mean value triplicate experiments. Primer <br /> as facilitates single-crossover integration target gene loci.        efficiency calculated slope best-fit linear <br /> The glmS ribozyme function efficiently 59 UTR                regression. (B) Expression normalizing gene BSD does not <br /> position similar fashion Sm1 hammerhead ribozyme,             change response sugar treatment. The change BSD <br /> shown P. falciparum [20]. Moreover, positioning glmS               expression parasites treated 10 mM sugar 24 h <br /> ribozyme 59 UTR efficient 39                  compared untreated parasites calculated using the <br /> UTR. This mRNA cleavage 59 UTR                       22(Cq treated-Cq untreated) transformation; error bars represent <br /> separate mRNA 59 cap structure. The de-capped                   S.E.M. To test null hypothesis treatment does cause <br /> mRNA susceptible degradation                         change BSD expression, two-tailed one-sample t-tests <br /> cytoplasmic 59&#226;&#8364;&#8220;39 exonclease XRN-1, acts rapidly                  comparing sample mean hypothetical mean = 1 were <br /> than 39 exosome acting de-adenylated mRNA [33].                       performed. The calculated P-values 0.9046, 0.0811, 0.36, <br />                                                                              0.605 reporter_glmS GlcN, reporter_M9 GlcN, reporter_glmS <br />    One caveat ribozyme system, common other <br />                                                                              Fru, reporter_M9 Fru respectively. <br /> inducible system, confounding effect inducing ligand <br />                                                                              (TIF) <br /> by itself. Although prolonged GlcN treatment high dose toxic <br /> to parasites [34], effective range GlcN concentration             Figure S2 Flow cytometry analysis GFP expressing <br /> glmS ribozyme mediated knockdown level toxicity              cells. Representative raw data scatter-plots flow cytometry <br /> causing cell death gross morphological change. On              experiments P. falciparum infected human erythrocytes are <br /> hand, possible GlcN toxicity confound phenotypic              shown. Control non-GFP expressing 3D7 wild-type parasite <br /> analysis essential gene knockdowns certain stages parasite          (untreated) shown A. Transgenic parasites shown <br /> development. In circumstances, inactive ribozyme                   (B) reporter_glmS (untreated), (C) reporter_M9 (untreated), (D) <br />  <br />  <br /> PLOS ONE | www.plosone.org                                               9                          August 2013 | Volume 8 | Issue 8 | e73783 <br />                                                                                                                        glmS Ribozyme Knockdown Plasmodium Genes <br />  <br />  <br /> reporter_glmS (10 mM GlcN treated) (E) reporter_M9                                        Table S1 Sequences oligonucleotides used study. <br /> (10 mM GlcN treated). The FL1 threshold 100 (arrowed)                                  (DOCX) <br /> chosen gating GFP-positive cells, cells counted as <br />                                                                                               Table S2 Genes significantly down-regulated wild-type 3D7 <br /> positive threshold control non-GFP expressing <br />                                                                                               P. falciparum following treatment 10 mM GlcN 24 h. <br /> parasites. <br /> (TIF)                                                                                         (XLSX) <br />  <br /> Figure S3 Fluorescence microscopy live parasites.                                          Acknowledgments <br /> Representative overlaid GFP/bright-field images (A) repor- <br /> ter_glmS (B) reporter_M9 transgenic parasites shown                               We thank Pavita Tipsombatboon, Chumpol Ngampiw, Jittima Piriya- <br /> control untreated left, 24 h treatment                                  pongsa Sissades Tongsima technical assistance analysis of <br />                                                                                               RNA-Seq data. <br /> 10 mM GlcN right. Images taken using Olympus <br /> BX51 microscope equipped Olympus DP71 digital <br /> camera DP controller software v 3.2.1.276. All images                                Author Contributions <br /> obtained using exposure time 1/3.5 s ISO sensitivity                               Conceived designed experiments: PP CW CU EK PJS. Performed <br /> ISO200.                                                                                       experiments: PP CW CU EK PJS. Analyzed data: PP SK YY EK <br /> (TIF)                                                                                         AAH PJS. Wrote paper: PJS AAH EK CU YY SK. <br />  <br /> References <br />  1. Technologies E (2011) A research agenda malaria eradication: basic science            19. Win MN, Smolke CD (2007) A modular extensible RNA-based gene- <br />     enabling technologies. PLoS Med 8: e1000399.                                              regulatory platform engineering cellular function. Proc Natl Acad Sci U S A <br />  2. El Bissati K, Zufferey R, Witola WH, Carter NS, Ullman B, et al. (2006) The                   104: 14283&#226;&#8364;&#8220;14288. <br />     plasma membrane permease PfNT1 essential purine salvage human               20. Agop-Nersesian C, Pfahler J, Lanzer M, Meissner M (2008) Functional <br />     malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A 103: 9286&#226;&#8364;&#8220;                   expression ribozymes Apicomplexa: exogenous control gene <br />     9291.                                                                                         expression inducible RNA-cleavage. Int J Parasitol 38: 673&#226;&#8364;&#8220;681. <br />  3. Combe A, Giovannini D, Carvalho TG, Spath S, Boisson B, et al. (2009) Clonal              21. Winkler WC, Nahvi A, Roth A, Collins JA, Breaker RR (2004) Control gene <br />     conditional mutagenesis malaria parasites. Cell Host Microbe 5: 386&#226;&#8364;&#8220;396.                   expression natural metabolite-responsive ribozyme. Nature 428: 281&#226;&#8364;&#8220;286. <br />  4. Collins CR, Das S, Wong EH, Andenmatten N, Stallmach R, et al. (2013)                     22. Watson PY, Fed <br /> </body></html>